Skip to main content
SpringerLink
Log in

Cytomegaloviral virus infection in bone marrow transplantation recipients: strategies for prevention and treatment

  • Review Articles
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Cytomegalovirus is major infectious pathogen following allogeneic bone marrow transplantation. In infected recipients, the virus is generally detected between 4 and 10 weeks after transplantation. Historically, CMV disease developed in 30–40% of seropositive recipients, the predominante manifestation being interstitial pneumonitis, which was generally lethal. Therapeutic interventions are discussed with special reference to the use of antiviral therapy for both treatment and prevention of CMV disease. The strategies developed in the bone marrow transplantation population to treat or prevent the development of CMV disease can be extrapolated to other patients groups who are immunosuppressed and at risk for developing clinical manifestations of CMV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bhawan J, Gellis S, Ucci A, Chang TW (1984) Vesiculobullous lesions caused by cytomegalovirus infection in an immunocompromised adult. J Am Acad Dermatol 27:743–747

    Google Scholar 

  2. Bowden RA, Sayers M, Gleaves CA, et al (1987) Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks. Transfusion 27:478–481

    Google Scholar 

  3. Bratanow NC, Ash RC, Turner PA, et al (1986) Successful treatment of serious cytomegalovirus disease with 9(1,3-dihydroxy-2propoxymethyl) guanine in bone marrow transplant (BMT) patients. Blood 68:280a

    Google Scholar 

  4. Cordonnier C, Escudier E, Nicolas JC, et al (1987) Evaluation of three assays on alveolar lavage fluid in the diagnosis of cytomegalovirus pneumonitis after bone marrow transplantation. J Infect Dis 155:495–500

    Google Scholar 

  5. Elfenbein GJ, Saral R (1981) Infectious disease during immune recovery after bone marrow transplatation. In: Allen JC (ed) Infection and the compromised host. Williams & Wilkins, Baltimore, pp 157–196

    Google Scholar 

  6. Emanuel D, Cunnigham I, Jule-elysee K et al (1988) Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with combination of ganciclovir and highdose intravenous immune globulin. Ann Intern Med 109:777–782

    Google Scholar 

  7. Funada H, Harada M, Yoshida T, et al (1984) Interstitial pneumonia after allogeneic and autologous bone marrow transplantation. Jpn J Clin Oncol 14:519–530

    Google Scholar 

  8. Goodrich JM, Mori M, Gleaves CA, et al (1991) Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 325:1601–1607

    Google Scholar 

  9. Guyotat D, Gibert R, Chomel J, et al (1987) Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantation. J Med Virol 23:393–399

    Google Scholar 

  10. Hersman J, Meyers JD, Thomas ED, et al (1982) The effect of granulocyte transfusion upon the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 96:149–152

    Google Scholar 

  11. Lonnqvist B, Rigden O, Wahren B, et al (1984) Cytomegalovirus infection associated with and preceding chronic graftversus-host disease. Transplantation 38:465–468

    Google Scholar 

  12. Marc ED, Cheng YC, Huang ES (1983) Effect of 9-(dihydroxy-2-propoxymetyl)guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother 24:518–521

    Google Scholar 

  13. Meyer JD, Flournoy N, Thomas ED (1982) Nonbacterial pneumonia after allogeneic bone marrow transplantation: a review of ten years experience. Rev Infect Dis 4:1119–1132

    Google Scholar 

  14. Meyers JE, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153:478–488

    Google Scholar 

  15. Miller W, Flynn P, McCullough J, et al (1986) Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood 67:1162–1167

    Google Scholar 

  16. Mutter W, Reddehase JM, Busch FW, Buhring H, Koszinowski UH (1988) Failure in generating hemopoietic stem cells in the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med 264:1645–1658

    Google Scholar 

  17. Paulin T, Ringden O, Lonnqvist B, et al (1986) The importance of pre bone marrow transplantation serology in determining subsequent cytomegalovirus infection. Scand J Infect Dis 18:199–209

    Google Scholar 

  18. Paulin T, Ringden O, Lonnqvist B (1987) Faster immunological recovery after bone marrow transplantation in patients without cytomegalovirus infection. Transplantation 39:377–384

    Google Scholar 

  19. Quinnan GV Jr, Kirmanani N, Rook AH, et al (1982) Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocytes and non T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus in bone marrow transplant recipients. N Engl J Med 307:7–13

    Google Scholar 

  20. Reddehase MJ, Weiland F, Munch K, et al (1985) Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 55:264–273

    Google Scholar 

  21. Reed EC, Bowden RA, Dandliker PS, et al (1988) Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus in patients with bone marrow transplants. Ann Intern Med 109:783–788

    Google Scholar 

  22. Reusser P, Riddel SR, Meyers JD, Greenberg PD (1991) Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373–1380

    Google Scholar 

  23. Riddel SR, Watanable KS, Goodrich JM et al (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238–241

    Google Scholar 

  24. Schmidt GJM, Horak DA, Niland JC, et al (1991) A randomized, controlled trial of prophylactic ganciclovir for cytomegalovrius pulmonary infection recipients of allogeneic bone marrow transplants. N Engl J Med 224:1005–1011

    Google Scholar 

  25. Shorr RI, Longo WL, Oberlcy TD, et al (1987) Cytomegalovirus-associated tubulointerstitial nephritis in an allogeneic bone marrow transplant recipient. Ann Intern Med 107:351–352

    Google Scholar 

  26. Verdonck LF, Van Heugten H, Gast GC de (1989) Delay in platelet recovery after bone marrow transplantation: impact of cytomegalovirus. Blood 66:921–925

    Google Scholar 

  27. Vilmer E, Mazeron MC, Rabian C, et al (1985) Clinical significance of cytomegalovirus viremia bone marrow transplantation. Transplantation 40:30–35

    Google Scholar 

  28. Wasserman R, August CS, Platokin SA (1988) Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J 7:109–115

    Google Scholar 

  29. Wilson EJ, Medearis DN Jr, Hansen LA, et al (1987) 9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice. Antimicrob Agents Chemother 31:1017–1020

    Google Scholar 

  30. Wingard JR, Chen YH, Burns WH, et al (1988) Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 71:1432–1437

    Google Scholar 

  31. Wingard JR, Sostrin MB, Vriesendorp HM, et al (1988) Interstitial pneumonitis following autologus bone marrow transplantation. Transplantation 46:61–65

    Google Scholar 

  32. Wingard JR, Piantadosi S, Burns WH,et al (1990) Cytomegalovirus infections in patients treated by intensive cytoreductive therapy with marrow transplant. Rev Infect Dis 12[Suppl 7]:793–804

    Google Scholar 

  33. Winston DJ, Pollard RB, Ho WG, et al (1982) Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med 97:11–18

    Google Scholar 

  34. Winston DJ, Huang ES, Miller MJ, et al (1985) Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. Ann Intern Med 102:16–20

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone Marrow Transplantation Program, Emory School of Medicine, 1365 Clifton Road, 30322, Atlanta, GA, USA

    H. Kent Holland & Rein Saral

Authors
  1. H. Kent Holland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rein Saral
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holland, H.K., Saral, R. Cytomegaloviral virus infection in bone marrow transplantation recipients: strategies for prevention and treatment. Support Care Cancer 1, 245–249 (1993). https://doi.org/10.1007/BF00366043

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00366043

Key words

Search

Navigation